Coadministration of encorafenib with delicate CYP3A4 substrates may well cause improved toxicity or lessened efficacy of these brokers.fentanyl transdermal and diazepam each increase sedation. Stay away from or Use Alternate Drug. Limit use to sufferers for whom different treatment method choices are insufficientmitotane decreases levels of diazepa